Home > Healthcare > Medical Devices > Diagnostic Devices > Endomyocardial Biopsy Market

Endomyocardial Biopsy Market Trends

Report ID: GMI6455
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Endomyocardial Biopsy Market Trends

The increasing number of heart transplants globally has led to a greater demand for endomyocardial biopsies. Endomyocardial biopsies are commonly performed after heart transplantations to monitor for rejection and other complications. An increase in the number of heart transplant surgeries contribute to the increasing demand for biopsies. According to the United Network for Organ Sharing, in 2022, nearly 42,887 organ transplants were performed in the U.S. Among these transplants, 8,409 were heart transplants.

Furthermore, the growing adoption of minimally invasive procedures in the field of cardiology has positively impacted the industry. Minimally invasive techniques are preferred by both patients and healthcare providers owing to its several advantages including smaller incisions, reduced post-operative pain, faster recovery times, shorter hospital stays, and lower risk of complications.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market value for endomyocardial biopsy was USD 321.5 million in 2022 and is estimated to account for USD 619.2 million by 2032.

The hospital segment accounted for over 51% share in industry in 2022 and is anticipated to witness significant growth through 2032 as hospitals with active heart transplant programs require regular and thorough monitoring of transplant recipients to detect early signs of rejection.

U.S. market accounted for USD 109 million in 2022 and will witness substantial growth through 2032 attributable to the presence of highly advanced & well-established healthcare infrastructure with specialized cardiac centers and cutting-edge medical technologies.

Argon Medica Devices, Inc, Cordis, Mermaid Medical, Terumo Corporation, Scholten Surgical Instruments, Inc., Changzhou Lookmed Medical Instrument Co., Ltd., Medtronic plc, Boston Scientific Corporation, Teleflex Incorporated, Cook Medical LLC and Merit Medical Systems, Inc. among others.